PERCEPTIVE ADVISORS LLC

Holdings History for Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Symbol: ACRV on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV)

04 Jun 2025 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV). This represents 0% ownership of the company. In their previous filing dated 01 May 2025, PERCEPTIVE ADVISORS LLC had reported owning 3,104,139 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Perceptive Advisors LLC	0%	-99%	$0	0	-3,104,139	-100%	$1.16	13G/A	02 Jun 2025	04 Jun 2025, 16:05
Perceptive Advisors LLC	9.9%		$4,811,415	3,104,139			$1.55	13G/A	29 Apr 2025	01 May 2025, 20:21

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.39%	$0	0	-5,360,858	-100%	$1.58	Q2 2025
31 Mar 2025	0.39%	0%	$10,882,542	5,360,858	0		$2.03	Q1 2025
31 Dec 2024	0.9%	0%	$32,272,365	5,360,858	0		$6.02	Q4 2024
30 Sep 2024	0.81%	0%	$37,526,006	5,360,858	0		$7.00	Q3 2024
30 Jun 2024	0.75%	+0.24%	$31,092,976	5,360,858	+2,353,000	+78%	$5.80	Q2 2024
31 Mar 2024	0.38%	0%	$21,506,185	3,007,858	0		$7.15	Q1 2024
31 Dec 2023	0.33%	0%	$14,798,661	3,007,858	0		$4.92	Q4 2023
30 Sep 2023	0.97%	0%	$28,755,122	3,007,858	0		$9.56	Q3 2023
30 Jun 2023	1.1%	0%	$38,981,840	3,007,858	0		$12.96	Q2 2023
31 Mar 2023	1.1%	0%	$38,169,718	3,007,858	0		$12.69	Q1 2023
31 Dec 2022	1%	+1%	$34,650,524	3,007,858	+3,007,858	NEW	$11.52	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.